查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403393

结构生物学和分子建模技术市场预测至 2030 年：按产品、工具、技术、应用和地区进行的全球分析

Structural Biology & Molecular Modeling Market Forecasts to 2030 - Global Analysis By Product, Tools (Software as a Service & Standalone Modeling, Visualization & Analysis, Databases and Other Tools), Technology, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球结构生物学和分子建模技术市场规模将达到49.1亿美元，预测期内复合年增长率为18.2%，预计到2030年将达到158.5亿美元。

结构生物学和分子建模技术是两个密切相关的领域，在分子层面上理解生物大分子的结构和功能方面发挥着重要作用。结构生物学和分子建模技术是多功能工具，可用于广泛的应用，从基础研究到医学、农业和工业的实际应用。在分子层面上理解生物过程有助于许多科学和技术领域的进步。

根据 2021 年 9 月发表在 MDPI日誌上的一篇研究论文，周边动脉疾病(PAD) 的盛行率估计在 3% 至 12% 之间，影响美国和欧洲约 2700 万人。

促生长因子：慢性病增加

慢性疾病通常涉及复杂的分子途径。结构生物学透过提供详细资讯来帮助识别和检验潜在的药物研发标靶。结构生物学和分子建模技术有助于潜在药物研发标靶的识别和特异性治疗药物的设计。癌症和神经退化性疾病等慢性病的增加加速了对标靶治疗和个体化治疗的需求。

成长抑制因素：对生物系统的了解有限

儘管取得了进步，我们对复杂生物系统的理解仍在不断发展中。对目标蛋白三维结构的有限了解阻碍了有效候选药物的识别和设计。结果，药物开发可能变得更慢、效率更低。此外，蛋白质-配体相互作用的预测准确性差和生物系统的复杂性等因素也阻碍了市场的成长。

机会：人工智慧 (AI) 集成

人工智慧（AI）和机器学习（ML）在结构生物学和分子建模技术过程中的整合提高了资料分析的速度和准确性。人工智慧演算法可以分析生物资料来识别潜在的药物研发标靶，为开发更有效率的药物研发管道、提高治疗效果并最大限度地减少副作用提供机会。我们提供此次整合将进一步提高该领域药物研发发现和开发的效率、准确性和整体成功率。

威胁：初期成本高

结构生物学和分子建模技术通常需要昂贵的设备、软体和熟练人员。它在很大程度上依赖尖端技术和专业设备。建立和维护最先进的实验室和专业设施也需要大量的资本投资。此外，与分析实验资料相关的成本，例如软体许可证和解释技术人员，也会增加整体初期成本并阻碍市场需求。

COVID-19 的影响

生命科学领域的许多研究工作都针对与新冠病毒相关的研究，包括疫苗开发、药物再利用以及病毒结构和功能的阐明。这种资源的重新分配也影响了与新冠病毒无关的研究领域，例如结构生物学和分子建模。疫情期间的经济不确定性和优先事项的转变给研究计划的资金筹措带来了挑战。此外，寻找新冠病毒治疗方法的迫切需求增加了人们对抗病毒药物发现的兴趣和投资，间接使结构生物学和分子建模领域受益。

电子显微镜领域预计将在预测期内成为最大的领域

电子显微镜领域预计将出现良好的成长。电子显微镜技术提供高解析度，使研究人员能够在分子甚至原子层面上可视化结构。电子显微镜是结构生物学和分子建模的强大工具，可提供对于理解生物过程和疾病机制至关重要的详细结构资讯，并促进药物研发工作。电磁技术的不断进步正在增加其在该领域的重要性。

药物研发领域预计在预测期内复合年增长率最高

预计药物研发领域在预测期内将出现最高的复合年增长率。结构生物学和分子建模技术透过提供对疾病分子机制的宝贵见解并促进新疗法的设计，在药物研发中发挥重要作用。这些技术可以帮助简化药物研发流程，使其更有效率且更具成本效益。

比最大的地区

由于投资的增加和研发的进步，预计亚太地区在预测期内将占据最大的市场占有率。亚太地区的製药和生物技术产业可能会对结构生物学和分子建模工具的需求做出重大贡献。此外，政府对科学研究和生物技术的措施和资助也可以对市场产生积极影响。

复合年增长率最高的地区

由于不断的进步、协作研究和伙伴关係，预计欧洲在预测期内将表现出最高的复合年增长率。政府资助、私人投资和津贴在促进该地区结构生物学和分子建模技术研究方面发挥着重要作用。欧洲市场的主要企业包括 Dassault Systemes、Agile Molecule 和 Acellera Limited。此外，资金筹措可用性和对个人化医疗日益增长的兴趣可能会影响欧洲市场的成长。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争关係

第五章全球结构生物学与分子建模技术市场：按产品

  • 试剂和套件
    • 蛋白质精製试剂
    • DNA和RNA萃取套件
    • 蛋白质结晶试剂
  • 装置
    • X射线结晶分析仪
    • 核磁共振 (NMR) 波谱仪
    • 质谱仪
  • 消耗品
    • 移液管和吸头
    • 微孔板
    • 低温储存
  • 其他产品

第六章全球结构生物学与分子建模技术市场：依工具分类

  • 软体即服务 (SaaS) 与独立建模
    • 分子动力学
    • 同源建模
    • 螺纹切削
    • 从头算
    • 混合
  • 视觉化和分析
  • 资料库
  • 其他工具

第七章全球结构生物学与分子建模技术市场：依技术分类

  • 电子显微镜
  • 核磁共振 (NMR) 光谱
  • 计算建模
  • 其他技术

第八章全球结构生物学与分子建模技术市场：依应用分类

  • 药物开发
  • 药物研发
  • 其他用途

第九章全球结构生物学与分子建模技术市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Acellera Limited
  • Thermo Fisher Scientific Inc
  • Illumina Inc.
  • Horiba
  • Chemical Computing Group ULC
  • Bruker Daltonics
  • Agilent Technologies Inc.
  • Charles River Laboratories
  • Dassault Systemes
  • Biomax Informatics AG
  • Agile Molecule
  • Bioinformatic LLC
Product Code: SMRC24618

According to Stratistics MRC, the Global Structural Biology & Molecular Modeling Market is accounted for $4.91 billion in 2023 and is expected to reach $15.85 billion by 2030 growing at a CAGR of 18.2% during the forecast period. Structural Biology and Molecular Modeling are two closely related fields that play a crucial role in understanding the structure and function of biological macromolecules at the molecular level. They are versatile tools with applications ranging from basic research to practical applications in medicine, agriculture, and industry. They provide a molecular-level understanding of biological processes, facilitating advancements in various scientific and technological fields.

According to the MDPI Journal research article published in September 2021, the prevalence of Peripheral Arterial Disease (PAD) is estimated to be 3-12%, affecting nearly 27 million people in America and Europe.

Market Dynamics:

Driver:

Rising incidence of chronic diseases

Chronic diseases often involve complex molecular pathways. Structural biology helps identify and validate potential drug targets by providing detailed information. Structural biology and molecular modeling contribute to the identification of potential drug targets and the design of specific therapeutics. The increasing prevalence of chronic diseases, such as cancer and neurodegenerative disorders, has fuelled the demand for targeted and personalized therapies.

Restraint:

Limited understanding of biological systems

Despite advancements, understanding of complex biological systems is still evolving. A limited understanding of the three-dimensional structures of target proteins can impede the identification and design of effective drug candidates. This can result in a slower and less efficient drug development process. Additionally, factors such as inaccuracy in predicting protein-ligand interactions and complexities of biological systems hampers the market growth.

Opportunity:

Integration of artificial intelligence (AI)

The integration of artificial intelligence (AI) and machine learning (ML) in structural biology and molecular modeling processes enhances the speed and accuracy of data analysis. AI algorithms can analyze biological data to identify potential drug targets. It presents opportunities for the development of more efficient drug discovery pipelines, improving treatment efficacy and minimizing side effects. This integration further enhances the efficiency, accuracy, and overall success rate of drug discovery and development efforts in this field.

Threat:

High initial costs

Structural biology and molecular modeling techniques often involve expensive equipment, software, and skilled personnel. They heavily rely on cutting-edge technologies and specialized equipment. Also, establishing & maintaining state-of-the-art laboratories and specialized facilities requires significant capital investment. Additionally, the costs associated with analyzing experimental data, including software licenses and skilled personnel for interpretation contribute to the overall initial expenses thereby hampering the market demand.

COVID-19 Impact

Many research efforts in the life sciences were redirected toward covid related studies, including vaccine development, drug repurposing, and understanding the virus's structure and function. This redirection of resources has impacted non-covid-related research areas, including structural biology and molecular modeling. Economic uncertainties and shifting priorities during the pandemic have led to funding challenges for research projects. Further, the urgency of finding treatments for covid has spurred increased interest and investment in antiviral drug discovery, which indirectly benefitted the structural biology and molecular modeling sector.

The electron microscopy segment is expected to be the largest during the forecast period

The electron microscopy segment is estimated to have a lucrative growth. Electron microscopy technique offers high resolution and allows researchers to visualize structures at the molecular and even atomic levels. It is a powerful tool in structural biology and molecular modeling, providing detailed structural information that is crucial for understanding biological processes, disease mechanisms, and facilitating drug discovery efforts. The continuous advancements in EM technology further contribute to its significance in the field.

The drug discovery segment is expected to have the highest CAGR during the forecast period

The drug discovery segment is anticipated to witness the highest CAGR growth during the forecast period. Structural biology and molecular modeling play crucial roles in drug discovery by providing valuable insights into the molecular mechanisms of diseases and facilitating the design of novel therapeutic agents. These techniques help streamline the drug discovery pipeline, making it more efficient and cost-effective.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing investments and advances in research and development. The pharmaceutical and biotechnology industries in the Asia Pacific region are likely to contribute significantly to the demand for structural biology and molecular modeling tools. Further, government initiatives and funding for scientific research and biotechnology can positively influence the market.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the continuous advancements, collaborations and partnerships. Government funding, private investments and grants play a significant role in advancing research in structural biology and molecular modeling in the region. Some prominent players in the European market include Dassault Systemes, Agile Molecule and Acellera Limited. Further, funding availability and growing emphasis on personalized medicine can impact the growth of the market in europe.

Key players in the market:

Some of the key players profiled in the Structural Biology & Molecular Modeling Market include Acellera Limited, Thermo Fisher Scientific Inc, Illumina Inc., Horiba, Chemical Computing Group ULC, Bruker Daltonics, Agilent Technologies Inc., Charles River Laboratories, Dassault Systemes, Biomax Informatics AG, Agile Molecule and Bioinformatic LLC.

Key Developments:

In November 2023, The Accelra Company released a new version of ACEMD, Accela's molecular dynamics simulation software. ACEMD is a highly optimized molecular dynamics (MD) engine that runs on NVIDIA GPUs. It's free for non-profit research, but commercial licenses are available for other uses.

In September 2023, Thermo Scientific launched the new Hydra Bio Plasma-Focused Ion Beam (Plasma-FIB) for cell biologists seeking simplified workflows while undertaking volume electron microscopy for cryo or resin-embedded samples. The Hydra Bio Plasma-FIB is a versatile, multi-application instrument that supports volume electron microscopy and sample preparation for the cryo-electron tomography workflow.

Products Covered:

  • Reagents & Kits
  • Instruments
  • Consumables
  • Other Products

Tools Covered:

  • Software as a Service (SaaS) & Standalone Modeling
  • Visualization & Analysis
  • Databases
  • Other Tools

Technologies Covered:

  • Electron Microscopy
  • Nuclear Magnetic Resonance (NMR) Spectroscopy
  • Computational Modeling
  • Other Technologies

Applications Covered:

  • Drug Development
  • Drug Discovery
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Structural Biology & Molecular Modeling Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents & Kits
    • 5.2.1 Protein Purification Reagents
    • 5.2.2 DNA & RNA Extraction Kits
    • 5.2.3 Protein Crystallization Reagents
  • 5.3 Instruments
    • 5.3.1 X-ray Crystallography Instruments
    • 5.3.2 Nuclear Magnetic Resonance (NMR) Spectrometers
    • 5.3.3 Mass Spectrometers
  • 5.4 Consumables
    • 5.4.1 Pipettes & Tips
    • 5.4.2 Microplates
    • 5.4.3 Cryogenic Storage
  • 5.5 Other Products

6 Global Structural Biology & Molecular Modeling Market, By Tools

  • 6.1 Introduction
  • 6.2 Software as a Service (SaaS) & Standalone Modeling
    • 6.2.1 Molecular Dynamics
    • 6.2.2 Homology Modeling
    • 6.2.3 Threading
    • 6.2.4 Ab Initio
    • 6.2.5 Hybrid
  • 6.3 Visualization & Analysis
  • 6.4 Databases
  • 6.5 Other Tools

7 Global Structural Biology & Molecular Modeling Market, By Technology

  • 7.1 Introduction
  • 7.2 Electron Microscopy
  • 7.3 Nuclear Magnetic Resonance (NMR) Spectroscopy
  • 7.4 Computational Modeling
  • 7.5 Other Technologies

8 Global Structural Biology & Molecular Modeling Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Development
  • 8.3 Drug Discovery
  • 8.4 Other Applications

9 Global Structural Biology & Molecular Modeling Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Acellera Limited
  • 11.2 Thermo Fisher Scientific Inc
  • 11.3 Illumina Inc.
  • 11.4 Horiba
  • 11.5 Chemical Computing Group ULC
  • 11.6 Bruker Daltonics
  • 11.7 Agilent Technologies Inc.
  • 11.8 Charles River Laboratories
  • 11.9 Dassault Systemes
  • 11.10 Biomax Informatics AG
  • 11.11 Agile Molecule
  • 11.12 Bioinformatic LLC

List of Tables

  • Table 1 Global Structural Biology & Molecular Modeling Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Structural Biology & Molecular Modeling Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Structural Biology & Molecular Modeling Market Outlook, By Reagents & Kits (2021-2030) ($MN)
  • Table 4 Global Structural Biology & Molecular Modeling Market Outlook, By Protein Purification Reagents (2021-2030) ($MN)
  • Table 5 Global Structural Biology & Molecular Modeling Market Outlook, By DNA & RNA Extraction Kits (2021-2030) ($MN)
  • Table 6 Global Structural Biology & Molecular Modeling Market Outlook, By Protein Crystallization Reagents (2021-2030) ($MN)
  • Table 7 Global Structural Biology & Molecular Modeling Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 8 Global Structural Biology & Molecular Modeling Market Outlook, By X-ray Crystallography Instruments (2021-2030) ($MN)
  • Table 9 Global Structural Biology & Molecular Modeling Market Outlook, By Nuclear Magnetic Resonance (NMR) Spectrometers (2021-2030) ($MN)
  • Table 10 Global Structural Biology & Molecular Modeling Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
  • Table 11 Global Structural Biology & Molecular Modeling Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 12 Global Structural Biology & Molecular Modeling Market Outlook, By Pipettes & Tips (2021-2030) ($MN)
  • Table 13 Global Structural Biology & Molecular Modeling Market Outlook, By Microplates (2021-2030) ($MN)
  • Table 14 Global Structural Biology & Molecular Modeling Market Outlook, By Cryogenic Storage (2021-2030) ($MN)
  • Table 15 Global Structural Biology & Molecular Modeling Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 16 Global Structural Biology & Molecular Modeling Market Outlook, By Tools (2021-2030) ($MN)
  • Table 17 Global Structural Biology & Molecular Modeling Market Outlook, By Software as a Service (SaaS) & Standalone Modeling (2021-2030) ($MN)
  • Table 18 Global Structural Biology & Molecular Modeling Market Outlook, By Molecular Dynamics (2021-2030) ($MN)
  • Table 19 Global Structural Biology & Molecular Modeling Market Outlook, By Homology Modeling (2021-2030) ($MN)
  • Table 20 Global Structural Biology & Molecular Modeling Market Outlook, By Threading (2021-2030) ($MN)
  • Table 21 Global Structural Biology & Molecular Modeling Market Outlook, By Ab Initio (2021-2030) ($MN)
  • Table 22 Global Structural Biology & Molecular Modeling Market Outlook, By Hybrid (2021-2030) ($MN)
  • Table 23 Global Structural Biology & Molecular Modeling Market Outlook, By Visualization & Analysis (2021-2030) ($MN)
  • Table 24 Global Structural Biology & Molecular Modeling Market Outlook, By Databases (2021-2030) ($MN)
  • Table 25 Global Structural Biology & Molecular Modeling Market Outlook, By Other Tools (2021-2030) ($MN)
  • Table 26 Global Structural Biology & Molecular Modeling Market Outlook, By Technology (2021-2030) ($MN)
  • Table 27 Global Structural Biology & Molecular Modeling Market Outlook, By Electron Microscopy (2021-2030) ($MN)
  • Table 28 Global Structural Biology & Molecular Modeling Market Outlook, By Nuclear Magnetic Resonance (NMR) Spectroscopy (2021-2030) ($MN)
  • Table 29 Global Structural Biology & Molecular Modeling Market Outlook, By Computational Modeling (2021-2030) ($MN)
  • Table 30 Global Structural Biology & Molecular Modeling Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 31 Global Structural Biology & Molecular Modeling Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 Global Structural Biology & Molecular Modeling Market Outlook, By Drug Development (2021-2030) ($MN)
  • Table 33 Global Structural Biology & Molecular Modeling Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 34 Global Structural Biology & Molecular Modeling Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.